TOT BIOPHARM International Company Limited (HKG:1875)

HKG:1875 Statistics

Total Valuation

HKG:1875 has a market cap or net worth of HKD 1.47 billion. The enterprise value is 1.48 billion.

Market Cap	1.47B
Enterprise Value	1.48B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1875 has 772.79 million shares outstanding.

Current Share Class	772.79M
Shares Outstanding	772.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.71%
Owned by Institutions (%)	n/a
Float	228.81M

Valuation Ratios

The trailing PE ratio is 37.25.

PE Ratio	37.25
Forward PE	n/a
PS Ratio	1.26
PB Ratio	1.89
P/TBV Ratio	1.91
P/FCF Ratio	n/a
P/OCF Ratio	11.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.95, with an EV/FCF ratio of -218.08.

EV / Earnings	40.11
EV / Sales	1.27
EV / EBITDA	13.95
EV / EBIT	37.57
EV / FCF	-218.08

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.54.

Current Ratio	1.79
Quick Ratio	1.43
Debt / Equity	0.54
Debt / EBITDA	3.96
Debt / FCF	-61.87
Interest Coverage	3.76

Financial Efficiency

Return on equity (ROE) is 4.91% and return on invested capital (ROIC) is 2.15%.

Return on Equity (ROE)	4.91%
Return on Assets (ROA)	1.58%
Return on Invested Capital (ROIC)	2.15%
Return on Capital Employed (ROCE)	3.39%
Revenue Per Employee	1.91M
Profits Per Employee	60,536
Employee Count	611
Asset Turnover	0.75
Inventory Turnover	2.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.86% in the last 52 weeks. The beta is -0.13, so HKG:1875's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-6.86%
50-Day Moving Average	1.90
200-Day Moving Average	1.87
Relative Strength Index (RSI)	50.24
Average Volume (20 Days)	85,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1875 had revenue of HKD 1.17 billion and earned 36.99 million in profits. Earnings per share was 0.05.

Revenue	1.17B
Gross Profit	832.64M
Operating Income	39.49M
Pretax Income	36.99M
Net Income	36.99M
EBITDA	104.59M
EBIT	39.49M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 405.72 million in cash and 420.85 million in debt, giving a net cash position of -15.12 million or -0.02 per share.

Cash & Cash Equivalents	405.72M
Total Debt	420.85M
Net Cash	-15.12M
Net Cash Per Share	-0.02
Equity (Book Value)	776.48M
Book Value Per Share	1.00
Working Capital	348.96M

Cash Flow

In the last 12 months, operating cash flow was 123.87 million and capital expenditures -130.68 million, giving a free cash flow of -6.80 million.

Operating Cash Flow	123.87M
Capital Expenditures	-130.68M
Free Cash Flow	-6.80M
FCF Per Share	-0.01

Margins

Gross margin is 71.24%, with operating and profit margins of 3.38% and 3.16%.

Gross Margin	71.24%
Operating Margin	3.38%
Pretax Margin	3.16%
Profit Margin	3.16%
EBITDA Margin	8.95%
EBIT Margin	3.38%
FCF Margin	n/a

Dividends & Yields

HKG:1875 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.52%
FCF Yield	-0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1875 has an Altman Z-Score of 0.55 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.55
Piotroski F-Score	5